11 Best Growth Company Stocks To Buy Now

Page 11 of 12

2. Biogen Inc (NASDAQ:BIIB)

– Number of Hedge Funds With Long Positions (as of March 31): 79

– Aggregate Value of Hedge Funds’ Holdings (as of March 31): $3.12 billion

Biogen Inc (NASDAQ:BIIB) is a global biopharmaceutical company that develops products and therapies for people suffering from serious neurological, rare and autoimmune diseases. As one of the pioneers in biotechnology, Biogen is focused on developing solutions for challenging diseases like Alzheimer’s and Parkinson’s disease. The U.S is Biogen’s primary market, with more than 70% of its total product revenue coming from the country. A leading portfolio of treatments and innovative R&D and technology has enabled the company to retain an industry leading position in the biopharma industry. Biogen has also grown its revenue by 65% in the last three years. As per our records, 79 hedge funds held shares in Biogen at the end of the first quarter, an increase of three quarter-over-quarter.

11 Best Growth Company Stocks To Buy Now

anyaivanova/Shutterstock.com

Follow Biogen Inc. (NASDAQ:BIIB)

Page 11 of 12